Transition from Basal Bolus to Once-Weekly Subcutaneous Semaglutide and Basal Insulin in Patients with Type 2 Diabetes Mellitus (TRANSITION-T2D)-A Prospective Randomized Controlled Trial

被引：0
|
作者：
Rodriguez, Paloma
Breslaw, Nikki
Bena, James F.
Xiao, Huijun
Jenkins, Kimberly
Isaacs, Diana
Zhou, Keren
Griebeler, Marcio L.
Burguera, Barto
Pantalone, Kevin M.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-74-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
74-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS COMPARING ONCE-WEEKLY SEMAGLUTIDE TO CONTROL THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES
    Pagada, A.
    Rai, M. K.
    Khadloya, T.
    VALUE IN HEALTH, 2018, 21 : S35 - S35
  • [32] Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study
    Frias, Juan
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Syring, Kristen
    Wullenweber, Paula
    Haupt, Axel
    Kazda, Christof
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (03): : 158 - 168
  • [33] Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial
    Kaku, Kohei
    Yamada, Yuichiro
    Watada, Hirotaka
    Abiko, Atsuko
    Nishida, Tomoyuki
    Zacho, Jeppe
    Kiyosue, Arihiro
    DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1202 - 1212
  • [34] Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Abrahamson, Martin J.
    Peters, Anne
    ANNALS OF MEDICINE, 2012, 44 (08) : 836 - 846
  • [35] Basal Plus Correction Versus Basal Bolus Insulin Regimen for the Management of Medical and Surgical Patients With Type 2 Diabetes: Basal Plus Trial
    Umpierrez, Guillermo
    Smiley, Dawn
    Hermayer, Kathie
    Olson, Darin E.
    Khan, Amna
    Newton, Christopher
    Fonseca, Vivian
    Jacobs, Sol
    Peng, Limin
    Pinzon, Ingrid
    Fereira, Maria
    Gore, Ashwini
    Hunt, Vickie
    Reyes, David
    Rizzo, Monica
    DIABETES, 2012, 61 : A271 - A271
  • [36] Once-Weekly Semaglutide in Patients with Peripheral Arterial Disease and Type 2 Diabetes-Comorbidities and Concomitant Medications from the STRIDE Trial
    Rasouli, Neda
    Catarig, Andrei-Mircea
    Hansen, Yasemin
    Houlind, Kim
    Ramesh, Chethana
    Ludvik, Bernhard
    Nordanstig, Joakim
    Sourij, Harald
    Verma, Subodh
    Bonaca, Marc P.
    DIABETES, 2024, 73
  • [37] Real-World Use of Once-Weekly Semaglutide in Thai Patients With Type 2 Diabetes Mellitus in a Private Hospital Setting
    Thewjitcharoen, Yotsapon
    Yenseung, Nalin
    Butadej, Siriwan
    Nakasatien, Soontaree
    Chotwanvirat, Phawinpon
    Chatchomchuan, Waralee
    Wanothayaroj, Ekgaluck
    Krittiyawong, Sirinate
    Himathongkam, Thep
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (01): : 21 - 28
  • [38] REAL WORLD TOLERABILITY AND EFFECTIVENESS OF EXENATIDE ONCE WEEKLY COMPARED TO BASAL INSULIN AMONG ELDERLY PATIENTS WITH TYPE 2 DIABETES (T2D)
    Seeger, J. D.
    Loughlin, A. M.
    Qiao, Q.
    Nunes, A. P.
    Ezzy, S.
    Yochum, L. A.
    Clifford, C. R.
    Gately, R.
    Ohman, P.
    Dore, D. D.
    VALUE IN HEALTH, 2016, 19 (07) : A668 - A668
  • [39] Glycemic Control with Once-Weekly Basal Insulin Fc (BIF) in Persons with Type 2 Diabetes Mellitus (T2DM) Using Continuous Glucose Monitoring (CGM) in a Phase 2 Study
    Kazda, Christof M.
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Wullenweber, Paula
    Haupt, Axel
    Frias, Juan P.
    DIABETES, 2021, 70
  • [40] The efficacy and safety of once-weekly, subcutaneous dulaglutide monotherapy compared to glimepiride in Asian patients with type 2 diabetes mellitus
    Wang, W.
    Huang, C. -N.
    Young, M. -C.
    Li, P.
    Gu, L.
    Yang, J.
    DIABETOLOGIA, 2015, 58 : S375 - S375
12345